Evidence map›Paper›PMID 28465620›Full record

ArticleScientific reports2017

IVIG regulates the survival of human but not mouse neutrophils.

Christoph Schneider, Simone Wicki, Stefanie Graeter, Tankica M Timcheva, Christian W Keller, Isaak Quast, Danila Leontyev, Iglika K Djoumerska-Alexieva, Fabian Käsermann, Stephan M Jakob and 7 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 34 citations in OpenAlex.

  1. Dying to Defend: Neutrophil Death Pathways and their Implications in Immunity.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  2. Human neutrophilsImmunological reviews · 2023
    Review
  3. Review
  4. Article
  5. Article
  6. Neutrophils Culture in Collagen Gel System.Frontiers in immunology · 2022
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Intravenous Immunoglobulin Therapy EliminatesInternational journal of molecular sciences · 2019
    Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 5 countries.

Christoph SchneiderInstitute of Pharmacology, University of Bern, Bern, Switzerland.
Simone WickiInstitute of Pharmacology, University of Bern, Bern, Switzerland.
Stefanie GraeterInstitute of Pharmacology, University of Bern, Bern, Switzerland.
Tankica M TimchevaInstitute of Pharmacology, University of Bern, Bern, Switzerland.
Christian W KellerInstitute of Experimental Immunology, Laboratory of Neuroinflammation, University of Zurich, Zurich, Switzerland.
Isaak QuastInstitute of Experimental Immunology, Laboratory of Neuroinflammation, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0001-6517-8537
Danila LeontyevDepartment of Medicine, University of Toronto and Centre for Innovation, Canadian Blood Services, Toronto, Ontario, Canada.
Iglika K Djoumerska-AlexievaDepartment of Immunology, Stefan Angelov Institute of Microbiology, Bulgarian Academy of Sciences, Sofia, Bulgaria.
Fabian KäsermannCSL Behring, Research, Bern, Switzerland.
Stephan M JakobDepartment of Intensive Care Medicine, University Hospital Bern (Inselspital), University of Bern, Bern, Switzerland.
Petya A DimitrovaDepartment of Immunology, Stefan Angelov Institute of Microbiology, Bulgarian Academy of Sciences, Sofia, Bulgaria.
Donald R BranchDepartment of Medicine, University of Toronto and Centre for Innovation, Canadian Blood Services, Toronto, Ontario, Canada.
Richard D CummingsDepartment of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Jan D LünemannInstitute of Experimental Immunology, Laboratory of Neuroinflammation, University of Zurich, Zurich, Switzerland.
Thomas KaufmannInstitute of Pharmacology, University of Bern, Bern, Switzerland.ORCID http://orcid.org/0000-0001-9906-874X
Hans-Uwe SimonInstitute of Pharmacology, University of Bern, Bern, Switzerland.
Stephan von GuntenInstitute of Pharmacology, University of Bern, Bern, Switzerland. stephan.vongunten@pki.unibe.ch.ORCID http://orcid.org/0000-0002-2753-8738
University of Bern · CHUniversity of Zurich · CHBulgarian Academy of Sciences · BGUniversity of Toronto · CABeth Israel Deaconess Medical Center · USCSL (Switzerland) · CH

Funding

Structural Basis of Immune Recognition of Glycosylated AntigensU54GM062116 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI SASISEKHARAN, RAM · 2001 to 2010
$80.3M
Overall Priority Score P41GM103694 · NIGMS · EMORY UNIVERSITY · PI CUMMINGS, RICHARD D · 2013 to 2018
$6.9M
Protein-Glycan Interaction Resource of the CFGR24GM098791 · NIGMS · EMORY UNIVERSITY · PI CUMMINGS, RICHARD D, PAULSON, JAMES C · 2011 to 2013
$2.6M
NIGMS NIH HHS P41 GM103694NIGMS NIH HHS R24 GM098791NIGMS NIH HHS U54 GM062116
6 · The paper itself

Abstract

Intravenous immunoglobulin (IVIG) are purified IgG preparations made from the pooled plasma from thousands of healthy donors and are being tested in preclinical mouse models. Inherent challenges, however, are the pluripotency of IVIG and its xenogeneicity in animals. IVIG can alter the viability of human neutrophils via agonistic antibodies to Fas and Siglec-9. In this study, we compared the effects of IVIG on human and mouse neutrophils using different death assays. Different commercial IVIG preparations similarly induced cytokine-dependent death in human neutrophils, whereas they had no effects on the survival of either peripheral blood or bone marrow neutrophils from C57BL/6 or BALB/c mice. F(ab')

Indexed as

AnimalsAntibodies, MonoclonalAntigens, CDCell Survivalfas ReceptorHumansImmunoglobulin Fc FragmentsImmunoglobulin GImmunoglobulins, IntravenousMiceMice, Inbred BALB CMice, Inbred C57BLNeutrophilsSialic Acid Binding Immunoglobulin-like LectinsAntibodies, MonoclonalAntigens, CDfas ReceptorImmunoglobulin Fc FragmentsImmunoglobulin GImmunoglobulins, IntravenousSialic Acid Binding Immunoglobulin-like LectinsSIGLEC9 protein, human

Identifiers

PMID28465620
PMCPMC5430961
OpenAlexW2609865146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.